David R. Ebsworth, Director at Verona Pharma plc (VRNA), bought 40,000 shares at $4.44 ($178K) on 2024-11-18, disclosed to the SEC on 2024-11-18.
Open-market purchase of $178k VRNA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.44 | 20,000 | $89K | 50.0% |
| 2 | $4.44 | 20,000 | $89K | 50.0% |
| Total | $4.44 avg | 40,000 | $178K | 100% |
| Filing → |
| VRNA | BUY | 2024-08-14 | $103K | — | Filing → |
| VRNA | BUY | 2023-11-08 | $317K | — | Filing → |
| VRNA | SELL | 2021-05-05 | $9K | — | Filing → |